Better Service by Doing Less: Introducing De-implementation Research in HIV.


Journal

Current HIV/AIDS reports
ISSN: 1548-3576
Titre abrégé: Curr HIV/AIDS Rep
Pays: United States
ID NLM: 101235661

Informations de publication

Date de publication:
10 2020
Historique:
pubmed: 15 8 2020
medline: 17 2 2021
entrez: 15 8 2020
Statut: ppublish

Résumé

The course of HIV research has led to a multitude of interventions to prevent and treat HIV. With the arrival of more effective interventions comes the need to end, or de-implement, less effective interventions. PURPOSE OF REVIEW: To describe the state of de-implementation research in HIV and provide a rationale for expanded research in this area. RECENT FINDINGS: Existing studies have identified a set of HIV-specific interventions appropriate for de-implementing and described the persistence of interventions that should be ended. However, to our knowledge, strategies to successfully promote appropriate de-implementation of HIV-specific interventions have not been examined. De-implementing interventions that are no longer needed is an opportunity to improve the quality and effectiveness of HIV services. Opportunities to expand this field of research abound.

Identifiants

pubmed: 32794070
doi: 10.1007/s11904-020-00517-y
pii: 10.1007/s11904-020-00517-y
pmc: PMC7492471
mid: NIHMS1620367
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

431-437

Subventions

Organisme : NIMH NIH HHS
ID : R21 MH115772
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States

Références

J Acquir Immune Defic Syndr. 2019 May 1;81(1):57-62
pubmed: 30964805
Milbank Q. 2016 Mar;94(1):126-62
pubmed: 26994712
Am J Community Psychol. 2018 Sep;62(1-2):189-202
pubmed: 29971792
Am J Prev Med. 2015 May;48(5):543-51
pubmed: 25891053
JAMA Intern Med. 2016 Nov 1;176(11):1687-1692
pubmed: 27654002
BMC Med. 2015 Oct 06;13:255
pubmed: 26444862
J Int AIDS Soc. 2019 Aug;22 Suppl 6:e25351
pubmed: 31468693
Int J Technol Assess Health Care. 2015 Jan;31(4):236-40
pubmed: 26290289
Ann Intern Med. 1998 Oct 1;129(7):573-8
pubmed: 9758579
Transl Behav Med. 2017 Dec;7(4):821-831
pubmed: 28397157
Lancet Infect Dis. 2018 Mar;18(3):e76-e86
pubmed: 29066132
JAMA. 2012 Apr 11;307(14):1513-6
pubmed: 22419800
JAMA Netw Open. 2019 Feb 1;2(2):e187621
pubmed: 30707224
BMJ. 2015 Aug 25;351:h4534
pubmed: 26306661
Implement Sci Commun. 2020 Jun 30;1:60
pubmed: 32885215
Healthc Manage Forum. 2016 Sep;29(5):214-7
pubmed: 27498394
J Acquir Immune Defic Syndr. 2019 Dec 1;82 Suppl 2:S113-S117
pubmed: 31658197
Lancet HIV. 2016 Jul;3(7):e307-17
pubmed: 27365205
JMIR Res Protoc. 2019 Nov 26;8(11):e15618
pubmed: 31769764
Implement Sci. 2017 Dec 4;12(1):144
pubmed: 29202782
Am J Public Health. 2012 May;102(5):789-99
pubmed: 22493997
Top Antivir Med. 2016 Jul/Aug;24(2):90-92
pubmed: 27841978
Patient Prefer Adherence. 2010 May 13;4:115-25
pubmed: 20517472
Implement Sci. 2015 Feb 13;10:24
pubmed: 25889285
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21647
pubmed: 28770599
Med Care Res Rev. 2017 Oct;74(5):507-550
pubmed: 27402662
BMC Med. 2015 Oct 20;13:273
pubmed: 26486727
AIDS Behav. 2012 Aug;16(6):1365-72
pubmed: 22610372
Ann Behav Med. 2016 Dec;50(6):920-934
pubmed: 27510956
J Int AIDS Soc. 2015 Dec 22;18:20572
pubmed: 26701080
Jt Comm J Qual Patient Saf. 2018 Dec;44(12):697-698
pubmed: 30447759
Ethn Dis. 2019 Feb 21;29(Suppl 1):93-96
pubmed: 30906155
Healthc (Amst). 2018 Jun;6(2):104-107
pubmed: 29279297

Auteurs

Virginia R McKay (VR)

The Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA. Virginia.mckay@wustl.edu.

Emmanuel K Tetteh (EK)

The Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA.

Miranda J Reid (MJ)

The Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA.

Lucy M Ingaiza (LM)

The Brown School, Washington University in St. Louis, St. Louis, MO, 63130, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH